PYMEPHARCO JOINT STOCK COMPANY

Business Type: Manufacturer (Factory)

Company Profile:

Pymepharco Joint Stock Company is a leading pharmaceutical enterprise based in Vietnam. Established in 1989, the company specializes in the research, development, production, and distribution of a wide range of pharmaceutical products. Pymepharco operates state-of-the-art manufacturing facilities that comply with international GMP-EU (Good Manufacturing Practice) standards. Its product portfolio includes antibiotics, cardiovascular drugs, analgesics, and various other therapeutic categories. The company is widely recognized for its commitment to high-quality healthcare solutions and has established a robust distribution network both domestically and in international markets. As a major player in the Vietnamese pharmaceutical industry, Pymepharco integrates advanced technology with stringent quality control processes to ensure the safety and efficacy of its medical products.

Pymepharco Joint Stock Company specializes in the production and distribution of pharmaceutical products. Their main product categories include:

1. Antibiotics and Anti-infectives

- Amoxicillin

- Ampicillin

- Cephalosporins (such as Cefixime, Cefuroxime)

- Azithromycin

2. Analgesics, Antipyretics, and Anti-inflammatory Drugs

- Paracetamol

- Ibuprofen

- Diclofenac

3. Cardiovascular Medications

- Amlodipine

- Atorvastatin

- Lisinopril

4. Gastrointestinal Drugs

- Omeprazole

- Esomeprazole

- Antacids

5. Respiratory Medications

- Cough syrups

- Expectorants

- Antihistamines (such as Loratadine, Cetirizine)

6. Vitamins and Supplements

- Vitamin C

- Vitamin B complex

- Multivitamin formulations

7. Ophthalmic Preparations

- Eye drops

- Eye ointments

8. Other Therapeutic Categories

- Dermatological creams and ointments

- Antidiabetic agents (such as Metformin)

- Medications for the nervous system

The company produces these in various dosage forms, including tablets, capsules, dry syrups, injections, and topical creams.